NovAccess Global Inc. (XSNX)

Market Cap	6.17K -99.2%
Revenue (ttm)	n/a
Net Income	-2.66M
EPS	-0.06
Shares Out	61.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,100
Average Volume	14,507
Open	0.0002
Previous Close	0.0001
Day's Range	0.0001 - 0.0002
52-Week Range	0.0000 - 0.0500
Beta	108.11
RSI	44.20
Earnings Date	May 14, 2026

About NovAccess Global

NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: XSNX